George Perez - Concepedia

Author

George Perez

Also Known As

G Perez, G Pérez, G. Friedland, G. Perez, G. Pérez, G. V. Perez, Gabriel Ernesto Melian Pérez, George Perez, George V. Pérez, Pérez, George V.

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Community Research Initiative University of Minnesota Centro de Ingeniería Genética y Biotecnología University of Havana Saint Michael's Medical Center

About

George Perez is an author at Community Research Initiative specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	419
2	Public Health	3	3	130
3	Social Sciences	2	2	58
4	Health Sciences	1	1	12
5	Natural Sciences	1	1	10

George Perez

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for Tuberculosis Fred M. Gordin, John P. Matts, Carol A. Miller, New England Journal of Medicine	1997	167
Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital? Hamid Shaaban, Sunil Daniel, R G Sison, Journal of Critical Care InflammationCritical Care MedicineUrban HospitalAcute CareInflammatory Marker	2010	122
Dental Health and Mortality in People With End-Stage Kidney Disease Treated With Hemodialysis: A Multinational Cohort Study Suetonia C. Palmer, Marinella Ruospo, Germaine Wong, American Journal of Kidney Diseases	2015	82
Prevalence and Characteristics of Hepatitis C Virus Coinfection in a Human Immunodeficiency Virus Clinical Trials Group: The Terry Beirn Community Programs for Clinical Research on AIDS Ellen Tedaldi, Katherine Huppler Hullsiek, Carlos Malvestutto, Clinical Infectious Diseases Hiv Clinical TrialsHepatitis CTreatment And PreventionViral HepatitisHuman Retrovirus	2003	67
Status of selected nutrients and progression of human immunodeficiency virus type 1 infection John D. Bogden, Francis W. Kemp, Shenggao Han, American Journal of Clinical Nutrition	2000	66
Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: Report from the heterosexual hiv transmission study George Perez, Joan Skurnick, Thomas N. Denny, International Journal of Infectious Diseases	1998	61
Primary Prophylaxis with Pyrimethamine for Toxoplasmic Encephalitis in Patients with Advanced Human Immunodeficiency Virus Disease: Results of a Randomized Trial Mark Z. Jacobson, C. Lynn Besch, Carroll Child, The Journal of Infectious Diseases	1994	57
Determination of the Underlying Cause of Death in Three Multicenter International HIV Clinical Trials Alan R. Lifson, Waldo Belloso, Cate Carey, HIV Clinical Trials	2008	52
Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial Leticia Rosario Cruz, Idania Baladrón, Aliusha Rittoles, ACS Pharmacology & Translational Science	2020	45
Development of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials Alan R. Lifson, Waldo Belloso, Richard T. Davey, HIV Clinical Trials	2010	44

Page 1